타시그나(닐로티닙)는 만성 골수성 백혈병(CML) 및 필라델피아 염색체 양성 급성 림프구성 백혈병(Ph+ ALL)을 포함한 특정 유형의 백혈병을 치료하는 데 사용되는 약물입니다. 그것은 암세포의 성장을 촉진하는 비정상적인 단백질의 작용을 차단함으로써 작용하는 티로신 키나아제 억제제로 알려진 약물 종류에 속합니다.
Tasigna는 일반적으로 하루에 한두 번 구두로 복용하며 캡슐 형태로 제공됩니다. 치료 용량 및 기간은 개인의 상태 및 치료에 대한 반응에 따라 달라질 수 있습니다.
Tasigna의 일반적인 부작용으로는 메스꺼움, 설사, 피로, 근육통 및 두통이 있습니다. 어떤 경우에는 감염이나 출혈의 위험 증가, 심장 문제 또는 췌장염과 같은 더 심각한 부작용을 일으킬 수도 있습니다.
타시그나를 복용하기 전에 귀하의 건강 상태나 복용 중인 약물, 알레르기 또는 약물에 대한 이전 반응을 담당 의사에게 알리는 것이 중요합니다. Tasigna는 다른 약물과 상호 작용할 수 있으므로 처방전 없이 구입할 수 있는 약물 및 보충제를 포함하여 귀하가 복용하고 있는 모든 약물에 대해 의료 서비스 제공자에게 알리는 것이 중요합니다.
전반적으로 타시그나는 특정 유형의 백혈병에 효과적인 치료 옵션이 될 수 있지만 의료 제공자의 지도와 감독 하에서만 복용해야 합니다. 백혈병 치료제인 타시그나가 현재 소뇌위축증 환자의 증상을 개선시킬 수 있는 유일한 희망이기에 하루빨리 의료급여 혜택을 적용시켜 더이상 이 질병으로 인한 사망사례가 좀 덜 나오길 희망합니다.
atrophy of the cerebellum
The cerebellum is part of the brain that plays an important role in coordinating movement and balance. Receives information from the body's sensory system and uses it to coordinate exercise commands, enabling smooth, coordinated movements.
The cerebellum also plays a role in maintaining posture and balance and is involved in the control of eye movement. In addition, the cerebellum is related to cognitive functions such as language, attention, and memory, but the degree to which it is involved remains a research topic. Overall, the cerebellum is an essential part of the brain that plays an important role in enabling and balancing smooth, coordinated movements.
Spinocherebellar generation (SCD) is a neurological condition involving progressive degeneration of the cerebellum and spinal cord. It's a kind of dyskinesia that refers to a group of disorders that affect coordination and balance. There are several types of SCDs, and the progression of symptoms and conditions can vary depending on the specific type.
Common symptoms of SCD include coordination and balance disorders, unstable walking, muscle weakness and stiffness, tremors, speaking and swallowing disorders, and vision problems. In some cases, SCD can lead to cognitive impairment and dementia.
The underlying cause of SCD is not fully understood, but it is thought to be caused by genetic mutations that affect the function and structure of the cerebellum and spinal cord. There are currently no treatments for SCD, and treatment options typically focus on symptom management and improved quality of life.
Treatment may include medication to manage symptoms such as physical therapy, tremor, or stiffness, as well as aids to mobility and other daily activities. In some cases, genetic counseling may be recommended for individuals with SCD genotypes.
symptoms of cerebellar atrophy
Cerebral atrophy is a neurological condition involving progressive degeneration of the cerebellum, which is part of the brain that plays an important role in coordinating movement and balance. This condition can occur as a result of a variety of root causes, including genetic disorders, infections, autoimmune diseases, and exposure to toxins.
Symptoms of cerebellum atrophy may vary depending on the root cause and degree of regression. However, common symptoms include.
👉 Loss of coordination: Cerebral atrophy can cause difficulties in balance, coordination, and fine motor ability. A person in a condition may have difficulty performing tasks that require walking, standing, or accurate movement.
👉 Muscle weakness: As the cerebellum degenerates, the muscles become weaker and less responsive.
👉 Difficulty in speaking: Cerebral atrophy can also affect the muscles involved in speaking, making it difficult to articulate and pronounce.
👉 Vision problems: In some cases, cerebellum atrophy can lead to vision problems such as double vision or impaired eye movement.
👉 Cognitive Disorder: As the condition progresses, it can also lead to cognitive impairment and difficulties in memory, attention, and other mental functions.
Currently, there is no cure for cerebellum atrophy, and treatment options generally focus on managing symptoms and slowing the progression of the condition. Treatment options may include physical therapy to improve balance and coordination, medication to manage symptoms such as muscle stiffness and tremor, and surgical interventions to address underlying conditions such as tumor or fluid buildup in the brain.
a treatment method
Not everyone can get hospital treatment for cerebellar atrophy. The reason is that medical insurance is not currently applied, so 2 million won is ridiculous even for a month of hospital expenses. Most of them are hereditary, and they can't walk well at first, and then die of general paralysis, which gradually stops the body. So, the biggest problem is that there is no medicine yet as a disease with a high suicide rate, which is a rare disease.
There are as many as 5,000 patients with cerebellar atrophy in Korea, which is not a small number. This is the only number of people identified, and considering the inheritance, we estimate about 10,000 people. It costs 2 million won a month to treat two pills a day. Can you handle it?
In any case, the drug prescribed as a treatment for cerebellar atrophy, called "Tasigna," is being used several years ago at Georgetown University because the results of administration to 15 patients with dementia were good.
Tarsigna (Nilotinib) is a drug used to treat certain types of leukemia, including chronic myeloid leukemia (CML) and Philadelphia chromosomal positive acute lymphocytic leukemia (Ph+ ALL). It belongs to a type of drug known as tyrosine kinase inhibitors that work by blocking the action of abnormal proteins that promote the growth of cancer cells.
Tasigna is typically taken verbally once or twice a day and is served in capsules. Treatment dose and duration may vary depending on the individual's condition and response to treatment.
Common side effects of Tasigna include nausea, diarrhea, fatigue, muscle pain and headaches. In some cases, it can cause more serious side effects, such as increased risk of infection or bleeding, heart problems, or pancreatitis.
Before taking Tascina, it is important to inform your doctor of your health condition or any previous reaction to the medication, allergy or medication you are taking. Tasigna can interact with other drugs, so it is important to inform your healthcare provider of all drugs you are taking, including over-the-counter drugs and supplements.
Overall, Tascina may be an effective treatment option for certain types of leukemia, but should only be taken under the guidance and supervision of a healthcare provider. Since Tarsigna, a leukemia treatment, is currently the only hope to improve symptoms in patients with cerebellum atrophy, we hope to apply medical benefits as soon as possible to reduce deaths from the disease.
댓글
댓글 쓰기